DE69918062D1 - 6,9-disubstituierte 2-(trans-(4-aminocyclohexyl)amino)purine - Google Patents

6,9-disubstituierte 2-(trans-(4-aminocyclohexyl)amino)purine

Info

Publication number
DE69918062D1
DE69918062D1 DE69918062T DE69918062T DE69918062D1 DE 69918062 D1 DE69918062 D1 DE 69918062D1 DE 69918062 T DE69918062 T DE 69918062T DE 69918062 T DE69918062 T DE 69918062T DE 69918062 D1 DE69918062 D1 DE 69918062D1
Authority
DE
Germany
Prior art keywords
aminocyclohexyl
disubstituted
purine
trans
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69918062T
Other languages
English (en)
Other versions
DE69918062T2 (de
Inventor
A Dumont
J Bitonti
R Borcherding
P Peet
Randall Munson
W Shum
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Aventis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharmaceuticals Inc filed Critical Aventis Pharmaceuticals Inc
Publication of DE69918062D1 publication Critical patent/DE69918062D1/de
Application granted granted Critical
Publication of DE69918062T2 publication Critical patent/DE69918062T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/16—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69918062T 1998-02-26 1999-02-18 6,9-disubstituierte 2-(trans-(4-aminocyclohexyl)amino)purine Expired - Fee Related DE69918062T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3238198A 1998-02-26 1998-02-26
US32381 1998-02-26
PCT/US1999/003451 WO1999043676A2 (en) 1998-02-26 1999-02-18 6,9-disubstituted 2-[trans-(4- aminocyclohexyl) amino]purines

Publications (2)

Publication Number Publication Date
DE69918062D1 true DE69918062D1 (de) 2004-07-22
DE69918062T2 DE69918062T2 (de) 2005-06-02

Family

ID=21864658

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69918062T Expired - Fee Related DE69918062T2 (de) 1998-02-26 1999-02-18 6,9-disubstituierte 2-(trans-(4-aminocyclohexyl)amino)purine

Country Status (30)

Country Link
EP (1) EP1056745B1 (de)
JP (1) JP2002504553A (de)
KR (1) KR100568658B1 (de)
CN (1) CN1128149C (de)
AP (1) AP1258A (de)
AR (1) AR019822A1 (de)
AT (1) ATE269332T1 (de)
AU (1) AU748178B2 (de)
BR (1) BR9908325A (de)
CA (1) CA2320448C (de)
CZ (1) CZ291604B6 (de)
DE (1) DE69918062T2 (de)
DK (1) DK1056745T3 (de)
EE (1) EE04315B1 (de)
ES (1) ES2219038T3 (de)
HU (1) HUP0100931A3 (de)
IL (2) IL138044A0 (de)
NO (1) NO20004281L (de)
NZ (1) NZ506234A (de)
OA (1) OA11480A (de)
PL (1) PL344021A1 (de)
PT (1) PT1056745E (de)
RU (1) RU2191777C2 (de)
SI (1) SI1056745T1 (de)
SK (1) SK12912000A3 (de)
TR (1) TR200002482T2 (de)
TW (1) TW541308B (de)
UA (1) UA62996C2 (de)
WO (1) WO1999043676A2 (de)
ZA (1) ZA991548B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6627633B2 (en) 1999-03-17 2003-09-30 Albany Molecular Research, Inc. 6-substituted biaryl purine derivatives as potent cyclin/CDK inhibitors and antiproliferative agents
US6969720B2 (en) 1999-03-17 2005-11-29 Amr Technology, Inc. Biaryl substituted purine derivatives as potent antiproliferative agents
DE60118521T2 (de) * 2000-01-07 2006-10-12 Universitaire Instelling Antwerpen Purin derivate, ihre herstellung und verwendung
YU54202A (sh) 2000-01-18 2006-01-16 Agouron Pharmaceuticals Inc. Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije
HN2001000008A (es) 2000-01-21 2003-12-11 Inc Agouron Pharmaceuticals Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo
FR2806626B1 (fr) * 2000-03-22 2003-11-28 Centre Nat Rech Scient Utilisation de substances modulatrices de l'expression ou de la fonction d'une proteine impliquee dans le cycle cellulaire pour le traitement ou la prevention des lesions neurales aigues
WO2001079198A1 (en) 2000-04-18 2001-10-25 Agouron Pharmaceuticals, Inc. Pyrazoles for inhibiting protein kinase
BR0113139A (pt) 2000-08-09 2003-06-24 Agouron Pharma Compostos, seus sais, formas multiméricas, pró-drogas ou metabólitos, composições farmacêuticas, método de tratamento de uma doença ou disfunção mediana através da inibição de cdk4 ou um complexo de cdk4/ciclina, método de tratamento de condição doentia em mamìferos mediada pela atividade de proteìna cinase e método de modulação ou inibição da atividade de um receptor de proteìna cinase
DE60110802T2 (de) 2000-08-18 2005-10-06 Agouron Pharmaceuticals, Inc., San Diego Heterozyklische-hydroximino-fluorene und ihre verwendung zur inhibierung von proteinkinasen
DK1377579T3 (da) * 2000-10-31 2009-08-31 Aventis Pharma Inc Acyl- og sulfonylderivater af 6,9-disubstitueret-2(trans-1,4-diaminocyklohexyl)puriner og deres anvendelse som antiproliferative midler
GB0117075D0 (en) * 2000-10-31 2001-09-05 Aventis Pharm Prod Inc Acyl and sulfonyl derivatives of 6, 9-distributed 2-(trans-1, 4-diaminocyclohexyl)-purines and their use as antiproliferative agents
US6756374B2 (en) 2001-01-22 2004-06-29 Hoffmann-La Roche Inc. Diaminothiazoles having antiproliferative activity
GB2378180B8 (en) 2001-06-27 2009-10-21 Cyclacel Ltd New purine derivatives
US6812232B2 (en) 2001-09-11 2004-11-02 Amr Technology, Inc. Heterocycle substituted purine derivatives as potent antiproliferative agents
US6667311B2 (en) 2001-09-11 2003-12-23 Albany Molecular Research, Inc. Nitrogen substituted biaryl purine derivatives as potent antiproliferative agents
GB0219054D0 (en) 2002-08-15 2002-09-25 Cyclacel Ltd New purine derivatives
GB0219052D0 (en) 2002-08-15 2002-09-25 Cyclacel Ltd New puring derivatives
WO2004069233A1 (ja) * 2003-02-04 2004-08-19 Kabushiki Kaisha Yakult Honsha 乳癌耐性蛋白阻害剤
US7211576B2 (en) 2004-04-20 2007-05-01 Hoffmann-La Roche Inc. Diaminothiazoles
JP5367563B2 (ja) * 2006-03-30 2013-12-11 ピーティーシー セラピューティクス，インコーポレーテッド ナンセンス突然変異を有するｄｎａからの機能的タンパク質の産生のための方法及びそれと関連した障害の治療
RU2681081C2 (ru) * 2007-10-05 2019-03-04 Верастэм, Инк. Пиримидинзамещенные производные пурина, фармацевтическая композиция на их основе, способ ингибирования протеинкиназ, способ лечения или профилактики заболеваний, чувствительных к ингибированию протеинкиназ, и способ лечения пролиферативных заболеваний
CN102241646B (zh) * 2010-05-14 2014-04-09 中国人民解放军军事医学科学院毒物药物研究所 己烯酮类化合物及其医药用途
WO2013130461A1 (en) 2012-02-29 2013-09-06 The Scripps Research Institute Wee1 degradation inhibitors
WO2015005491A1 (ja) * 2013-07-12 2015-01-15 国立大学法人京都大学 疾病の発症又は進行の一因となる異常スプライシングを抑制できる物質のスクリーニング方法
PT3244891T (pt) 2015-01-16 2022-10-20 Massachusetts Gen Hospital Compostos para melhorar o splicing do arnm
CN107903274A (zh) * 2017-12-28 2018-04-13 窦玉玲 一种胺类化合物及其在抗肿瘤药物中的应用
WO2021016263A1 (en) * 2019-07-21 2021-01-28 University Of Virginia Patent Foundation Cysteine binding compositions and methods of use thereof
WO2024105159A1 (en) * 2022-11-16 2024-05-23 University Of Zurich Ligands of the m6a-rna readers

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9301000D0 (en) * 1993-01-20 1993-03-10 Glaxo Group Ltd Chemical compounds
GB9414208D0 (en) * 1994-07-14 1994-08-31 Glaxo Group Ltd Compounds
BR9611157A (pt) * 1995-11-01 1999-03-30 Novartis Ag Derivados de purina e processos para sua preparação
FR2741881B1 (fr) * 1995-12-01 1999-07-30 Centre Nat Rech Scient Nouveaux derives de purine possedant notamment des prorietes anti-proliferatives et leurs applications biologiques

Also Published As

Publication number Publication date
WO1999043676A2 (en) 1999-09-02
ZA991548B (en) 1999-08-26
NZ506234A (en) 2003-05-30
SK12912000A3 (sk) 2001-08-06
CZ20003106A3 (cs) 2000-12-13
DE69918062T2 (de) 2005-06-02
CN1128149C (zh) 2003-11-19
CN1291983A (zh) 2001-04-18
NO20004281L (no) 2000-10-18
DK1056745T3 (da) 2004-10-25
EP1056745A2 (de) 2000-12-06
SI1056745T1 (en) 2004-12-31
BR9908325A (pt) 2000-11-07
EP1056745B1 (de) 2004-06-16
HK1030948A1 (en) 2001-05-25
NO20004281D0 (no) 2000-08-25
IL138044A0 (en) 2001-10-31
AU3299099A (en) 1999-09-15
TR200002482T2 (tr) 2002-10-21
AR019822A1 (es) 2002-03-20
TW541308B (en) 2003-07-11
HUP0100931A2 (hu) 2002-04-29
AP1258A (en) 2004-03-15
CA2320448C (en) 2005-02-01
KR20010041315A (ko) 2001-05-15
IL138044A (en) 2006-04-10
OA11480A (en) 2004-05-05
ES2219038T3 (es) 2004-11-16
ATE269332T1 (de) 2004-07-15
CZ291604B6 (cs) 2003-04-16
EE04315B1 (et) 2004-06-15
PL344021A1 (en) 2001-09-24
WO1999043676A3 (en) 1999-10-21
UA62996C2 (en) 2004-01-15
KR100568658B1 (ko) 2006-04-07
EE200000501A (et) 2002-02-15
RU2191777C2 (ru) 2002-10-27
AU748178B2 (en) 2002-05-30
HUP0100931A3 (en) 2002-08-28
JP2002504553A (ja) 2002-02-12
AP2000001923A0 (en) 2000-09-30
PT1056745E (pt) 2004-09-30
CA2320448A1 (en) 1999-09-02

Similar Documents

Publication Publication Date Title
DE69918062D1 (de) 6,9-disubstituierte 2-(trans-(4-aminocyclohexyl)amino)purine
NO20004280L (no) 6,9-disubstituerte 2-[trans-(4-aminocykloheksyl)amino]puriner
NO20034929L (no) 4-amino-5-fenyl-7-cyklobutylpyrrol(2,3-D)pyrimidinderivater
DK2308855T3 (da) 2,4-Diaminopyrimidinderivater
DE69902758D1 (de) 2-(purin-9-yl)-tetrahydrofuran-3,4-diol-derivative
ID27595A (id) SENYAWA-SENYAWA PIROLO (2,3-d) PIRIMIDINA
ID29241A (id) Turunan-turunan kinolin teranelasi-1,2
NO20040540L (no) 4-amino-6-fenylpyrrolo[2,3-D]pyrimidinderivater.
DK0891978T3 (da) 5H-Thiazol(3,2-a)pyrimidinderivativer
ID21413A (id) Turunan-turunan 1,3,8,-triaza-spiro (4,5) dekan-4-on
PT1210349E (pt) Pirazolo-¬4,3-d|-pirimidinas
NO981846D0 (no) Beskyttelsesbrille, spesielt arbeidsbeskyttelsesbrille
ATE234839T1 (de) 4,5-azolo-oxindole
ATE234302T1 (de) Di- oder triazaspiro(4,5)decanderivate
DE69912248D1 (de) 6,9-disubstituierte 2-[trans-(4-aminocyclohexyl)amino] purine
ID26368A (id) Turunan-turunan 2 deoksi higromisin
IS7131A (is) Nýjar 2,4-díamínóþíasól afleiður
SI1056744T1 (en) 6,9-disubstituted 2- trans-(4- aminocyclohexyl) amino)purines
ID26084A (id) Turunan-turunan amino antrasiklinon
IS7299A (is) 3,4-díhýdró-1H-ísókínólóín-2-ýl-afleiður
ES1039871Y (es) Colgante perfeccionado.
IT1292672B1 (it) Dispositivo per la frattazzatura di superfici.
ES1041780Y (es) Vitrina perfeccionada.
ES1049950Y (es) Luminaria multiple perfeccionada.
FI3282U1 (fi) Iskulaite

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC

8327 Change in the person/name/address of the patent owner

Owner name: AVENTIS HOLDINGS INC., GREENVILLE, DEL., US

8339 Ceased/non-payment of the annual fee